Trial intelligence / Profile preview

ASTRONAUT: Aliskiren in Acute Decompensated Heart Failure

NCT00894387Phase 3Completed

Sponsor
Novartis
Start
May 2009
Primary completion
Aug 2012
Modality
Small Molecules
Countries
24
01

Overview

A Phase 3 trial of aliskiren in heart failure (HF), sponsored by Novartis. Started May 2009; status: completed.

02

Drugs

aliskiren
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00894387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00894387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call